Regulatory Decisions in a Globalised World
- 1 January 2002
- journal article
- Published by Springer Nature in Drug Safety
- Vol. 25 (10) , 689-693
- https://doi.org/10.2165/00002018-200225100-00001
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The FDA, Regulation, and the Risk of StrokeNew England Journal of Medicine, 2000
- Phenylpropanolamine and the Risk of Hemorrhagic StrokeNew England Journal of Medicine, 2000
- Phenylpropanolamine and other OTC alpha-adrenergic agonists.2000
- Phenylpropanolamine in drugs could be a risk for stroke.2000
- Adverse drug effects attributed to phenylpropanolamine: A review of 142 case reportsThe American Journal of Medicine, 1990
- PHENYLPROPANOLAMINE AND CEREBRAL HAEMORRHAGEThe Lancet, 1984
- STROKE AND PHENYLPROPANOLAMINE USEThe Lancet, 1983
- Clinical pharmacology. Adverse reactions to drugs.BMJ, 1981
- HAZARDS OF THE APPETITE SUPPRESSANT PHENYLPROPANOLAMINEThe Lancet, 1979
- SEVERE HYPERTENSION AFTER INGESTION OF AN APPETITE SUPPRESSANT (PHENYLPROPANOLAMINE) WITH INDOMETHACINThe Lancet, 1979